AI assistant
Sending…
NovoCure Ltd — Director's Dealing 2018
Jul 18, 2018
31949_dirs_2018-07-18_cb0bb682-2ff2-4619-83c3-a55a09d4fec8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-07-16
Reporting Person: DOYLE WILLIAM F (Director, Executive Chairman)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-07-16 | Ordinary Shares | M | 2330 | $3.59 | Acquired | 914473 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-07-16 | Warrants | $3.59 | M | 2330 | Disposed | 2018-07-21 | Ordinary Shares (2330) | Direct |
Footnotes
F1: Exercisable at any time through July 21, 2018
More from NovoCure Ltd
Proxy Solicitation & Information Statement
2026
May 21
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3